ADRISTES Trademark

Trademark Overview


On Monday, June 7, 2010, a trademark application was filed for ADRISTES with the United States Patent and Trademark Office. The USPTO has given the ADRISTES trademark a serial number of 85056179. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 16, 2012. This trademark is owned by Pfizer Inc.. The ADRISTES trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, hematologic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurological, oncological, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction and pain; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations; vaccines for human use
adristes

General Information


Serial Number85056179
Word MarkADRISTES
Filing DateMonday, June 7, 2010
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 16, 2012
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 19, 2010

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, hematologic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurological, oncological, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction and pain; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations; vaccines for human use

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, June 11, 2010
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events


Event DateEvent Description
Monday, July 16, 2012ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, July 16, 2012ABANDONMENT - NO USE STATEMENT FILED
Saturday, October 15, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, October 14, 2011EXTENSION 2 GRANTED
Wednesday, October 12, 2011EXTENSION 2 FILED
Friday, October 14, 2011CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, October 12, 2011TEAS EXTENSION RECEIVED
Wednesday, April 27, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 25, 2011EXTENSION 1 GRANTED
Monday, April 25, 2011EXTENSION 1 FILED
Monday, April 25, 2011TEAS EXTENSION RECEIVED
Tuesday, December 14, 2010NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 19, 2010OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 19, 2010PUBLISHED FOR OPPOSITION
Thursday, September 16, 2010LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, September 16, 2010ASSIGNED TO LIE
Tuesday, September 7, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, August 31, 2010ASSIGNED TO EXAMINER
Friday, June 11, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, June 10, 2010NEW APPLICATION ENTERED IN TRAM